RESUMO
Context: Satureja khuzistanica Jamzad. (Lamiaceae), is known for its antifungal and antioxidant compounds, especially rosmarinic acid (RA).Objective: The study examines the effect of elicitors on RA production and phytochemical properties of S. khuzistanica.Materials and methods: In vitro plants were treated with methyl jasmonate (MeJA) and multi-walled carbon nanotubes (MWCNTs). In vivo plants were treated with MWCNTs and salicylic acid (SA). RA was measured by HPLC. Catalase (CAT), guaiacol peroxidase (POD) and ascorbate peroxidase (APX) were quantified. DPPH and ß-carotene were assayed in in vivo extracts. The antifungal effects of extracts were evaluated against Fusarium solani K (FsK).Results: The highest RA contents of in vitro plants were 50 mg/L MeJA (140.99 mg/g DW) and 250 mg/L MWCNTs (140.49 mg/g DW). The highest in vivo were 24 h MWCNTs (7.13 mg/g DW) and 72 h SA (9.12 mg/g DW). The maximum POD and APX activities were at 100 mg/L MeJA (5 and 4 mg protein, respectively). CAT had the highest activities at 50 mg/L MeJA (2 mg protein). DPPH and ß-carotene showed 50% and 80% inhibition, respectively. The FsK aggregation was the lowest for in vitro extract in number of conidia [1.82 × 1010], fresh weight (6.51 g) and dry weight (0.21 g) that proved RA inhibitory effects. The callus reduces FsK growth diameter to 2.75 on the 5th day.Discussion and conclusions: Application of MeJA, SA, and MWCNTSs could increase RA in S. khuzistanica and highlighted potential characteristics in pharmaceutical and antifungal effects.
Assuntos
Cinamatos/análise , Cinamatos/farmacologia , Depsídeos/análise , Depsídeos/farmacologia , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Reguladores de Crescimento de Plantas/farmacologia , Satureja/química , Satureja/metabolismo , Acetatos/farmacologia , Antifúngicos/análise , Antifúngicos/farmacologia , Antioxidantes/análise , Antioxidantes/farmacologia , Ascorbato Peroxidases/biossíntese , Ascorbato Peroxidases/metabolismo , Catalase/biossíntese , Catalase/metabolismo , Ciclopentanos/farmacologia , Fusarium/crescimento & desenvolvimento , Nanotubos de Carbono , Oxilipinas/farmacologia , Peroxidase/biossíntese , Peroxidase/metabolismo , Compostos Fitoquímicos , Ácido Salicílico/farmacologia , Ácido RosmarínicoRESUMO
BACKGROUND: Several studies described the phytochemical constituents of plants in relation with the free radical scavenging property and inhibition of lipid peroxidation. This study investigated the in vitro antioxidant property, and the protective effects of ethanolic and aqueous ethanol extract of the leaves and barks of Afrostyrax lepidophyllus (Huaceae) against ion mediated oxidative damages. METHODS: Four extracts (ethanol and aqueous-ethanol) from the leaves and barks of A. lepidophyllus were used in this study. The total phenols content, the antiradical and antioxidant properties were determined using standard colorimetric methods. RESULTS: The plant extracts had a significant scavenging potential on the 2,2-diphenyl-1-picrylhydrazyl (DPPH), hydroxyl (OH), nitrite oxide (NO) and 2,2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid (ABTS) radicals with the IC50 varied between 47 and 200 µg/mL depending on the part of plant and the type of extract. The ethanol extract of A. lepidophyllus bark (GEE) showed the highest polyphenolic (35.33 ± 0.29) and flavonoid (12.00 ± 0.14) content. All the tested extracts demonstrated a high protective potential with the increased of superoxide dismutase, catalase and peroxidase activities. CONCLUSION: Afrostyrax lepidophyllus extracts exhibited higher antioxidant potential and significant protective potential on liver enzymes.
Assuntos
Sequestradores de Radicais Livres , Fígado/enzimologia , Oxigênio/química , Casca de Planta/enzimologia , Extratos Vegetais/química , Árvores , Animais , Antioxidantes/química , Benzotiazóis/química , Compostos de Bifenilo , Catalase/biossíntese , Catalase/metabolismo , Colorimetria , Etanol/química , Flavonoides/química , Radicais Livres , Radical Hidroxila/química , Concentração Inibidora 50 , Íons , Peroxidação de Lipídeos , Molibdênio/química , Óxido Nítrico/química , Peroxidase/biossíntese , Fenol/química , Picratos , Análise de Componente Principal , Ratos , Ratos Wistar , Ácidos Sulfônicos/química , Superóxido Dismutase/biossínteseRESUMO
The phytase of the yeast Pichia anomala is a histidine acid phosphatase based on signature sequences and catalytic amino acids identified by site-directed mutagenesis. Among modulators, N-bromosuccinimide and butanedione inhibit phytase, while Ca(2+) and Ni(2+) stimulate slightly. Vanadate exhibits competitive inhibition of phytase, making it bifunctional to act as haloperoxidase. Molecular docking supports vanadate to share its binding site with phytate. The T 1/2, activation energy (E a ), temperature quotient (Q 10), activation energy of thermal inactivation (Ed), and enthalpy (ΔH d (0) ) of the enzyme are 4.0 min (80 °C), 27.72 kJ mol(-1), 2.1, 410.62 kJ mol(-1), and â¼407.8 kJ mol(-1) (65-80 °C), respectively. The free energy of the process (ΔG d (o) ) increases from 49.56 to 71.58 kJ mol(-1) with rise in temperature, while entropy of inactivation (ΔS d (0) ) remains constant at â¼1.36 kJ mol(-1) K(-1). The supplementation of whole wheat dough with rPPHY resulted in 72.5 % reduction in phytic acid content of bread. These characteristics confirm that the phytase has adequate thermostability for its applicability as a food and feed additive.
Assuntos
6-Fitase/metabolismo , Peroxidase/biossíntese , Pichia/enzimologia , 6-Fitase/antagonistas & inibidores , 6-Fitase/química , 6-Fitase/genética , Sequência de Aminoácidos , Biocatálise/efeitos dos fármacos , Pão , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Cinética , Modelos Moleculares , Dados de Sequência Molecular , Mutação/genética , Peroxidase/metabolismo , Desnaturação Proteica/efeitos dos fármacos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Tartaratos/farmacologia , Temperatura de Transição , Triticum , Vanadatos/farmacologiaRESUMO
The effect of exogenously applied hydrogen peroxide on salt stress tolerance was investigated in Panax ginseng. Pretreatment of ginseng seedlings with 100 µM H2O2 increased the physiological salt tolerance of the ginseng plant and was used as the optimum concentration to induce salt tolerance capacity. Treatment with exogenous H2O2 for 2 days significantly enhanced salt stress tolerance in ginseng seedlings by increasing the activities of ascorbate peroxidase, catalase and guaiacol peroxidase and by decreasing the concentrations of malondialdehyde (MDA) and endogenous H2O2 as well as the production rate of superoxide radical (O2(-)). There was a positive physiological effect on the growth and development of salt-stressed seedlings by exogenous H2O2 as measured by ginseng dry weight and both chlorophyll and carotenoid contents. Exogenous H2O2 induced changes in MDA, O2(-), antioxidant enzymes and antioxidant compounds, which are responsible for increases in salt stress tolerance. Salt treatment caused drastic declines in ginseng growth and antioxidants levels; whereas, acclimation treatment with H2O2 allowed the ginseng seedlings to recover from salt stress by up-regulation of defense-related proteins such as antioxidant enzymes and antioxidant compounds.
Assuntos
Peróxido de Hidrogênio/farmacologia , Panax/efeitos dos fármacos , Tolerância ao Sal/efeitos dos fármacos , Antioxidantes/metabolismo , Ascorbato Peroxidases/biossíntese , Catalase/biossíntese , Panax/crescimento & desenvolvimento , Panax/metabolismo , Peroxidase/biossíntese , Plântula/efeitos dos fármacos , Estresse Fisiológico/efeitos dos fármacosRESUMO
Changes in the enzymatic activity of phenol-dependent peroxidase (PO) of vacuoles and tissue extract of red beet (Beta vulgaris L.) roots in different phases of plant development and in hyperosmotic stress and pathogen infection were found. The highest activity was observed during root growth and the lowest PO activity occurred in dormancy, respectively. Activation of the enzyme was observed in infected roots. The isozyme composition of PO was characterized by lability, and the number of cationic isoforms varied significantly. The optimum pH of the enzyme changed depending on the growth phase and stressor, tending to shift towards low values at rest and in hyperosmotic stress. The shift in the optimum pH coincided with the appearance of additional cationic PO isoforms.
Assuntos
Beta vulgaris/fisiologia , Isoenzimas/genética , Peroxidase/genética , Raízes de Plantas/fisiologia , Beta vulgaris/enzimologia , Isoenzimas/biossíntese , Pressão Osmótica , Peroxidase/biossíntese , Raízes de Plantas/enzimologia , Extratos de Tecidos/metabolismo , Vacúolos/enzimologiaRESUMO
OBJECTIVE: Sepsis is a systemic inflammatory response syndrome. Emodin is a major ingredient of Rheum Palmatum, a Chinese herb that is widely used in China for treatment of endotoxemia-related diseases. This study intended to examine the effect of Emodin on LPS-induced rat mesenteric microcirculatory disturbance and the underlying mechanisms. METHODS: The male Wistar rats received LPS (5 mg/kg/hr) for 90 min, with or without administration of Emodin (10 mg/kg/hr) by enema 30 min before (pre-treatment) or after (post-treatment) LPS infusion, and the dynamics of mesenteric microcirculation were determined by inverted intravital microscopy. Expression of adhesion molecules and TLR4, NF-κB p65, ICAM-1, MPO, and AP-1 in mesentery tissue was evaluated by flow cytometry and Western-blot, respectively. RESULTS: Pre or post-treatment with Emodin significantly ameliorated LPS-induced leukocyte emigration, reactive oxygen species production and albumin leakage, and the expression of TLR4, NF-κB p65, ICAM-1, MPO and AP-1 in mesentery. CONCLUSIONS: These results demonstrate the beneficial role of Emodin in attenuating the LPS-induced microcirculatory disturbance, and support the use of Emodin for patients with endotoxemia.
Assuntos
Emodina/farmacologia , Lipopolissacarídeos/toxicidade , Mesentério , Microcirculação/efeitos dos fármacos , Inibidores de Proteínas Quinases/farmacologia , Fluxo Sanguíneo Regional/efeitos dos fármacos , Animais , Endotoxemia/induzido quimicamente , Endotoxemia/tratamento farmacológico , Endotoxemia/metabolismo , Endotoxemia/fisiopatologia , Humanos , Molécula 1 de Adesão Intercelular/biossíntese , Masculino , Mesentério/irrigação sanguínea , Mesentério/metabolismo , Mesentério/patologia , Mesentério/fisiopatologia , Peroxidase/biossíntese , Ratos , Ratos Wistar , Receptor 4 Toll-Like/biossíntese , Fator de Transcrição AP-1/biossíntese , Fator de Transcrição RelA/biossínteseRESUMO
Oxidative stress significantly contributes to cisplatin (CP)-associated cytotoxicity, and use of antioxidants could counteract such cytotoxic effects of CP. The major biochemical pathway for reactive oxygen species (ROS) formation proceeds through O2â» production, which is generated by NADPH oxidase, such oxidative stress can activate p38 MAPK to intensify the cytotoxic effect of CP. We mainly aimed to study the protective effect of oxytocin (OT) on CP-induced nephrotoxicity whereas; it was previously shown to have anti-inflammatory effects in different inflammation models. Administration of OT significantly decreased the gene expression of both NADPH oxidase and P38 MAPK, nitric oxide (NO), myloperoxidase (MPO), and TBARS, furthermore it increased the renal tissue levels of antioxidants; reduced glutathione (GSH), and superoxide dismutase (SOD). Histologically, OT reduced the monocellular infiltration as well as the tubular damage in CP-induced nephrotoxicity. In conclusion OT has a powerful antioxidant effect that can alleviate the CP-induced nephrotoxicity through inhibition of NADPH oxidase and P38 MAPK resulting in improvement of kidney functions.
Assuntos
Cisplatino/toxicidade , Nefropatias/induzido quimicamente , NADPH Oxidases/antagonistas & inibidores , Ocitocina/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Animais , Avaliação Pré-Clínica de Medicamentos , Indução Enzimática/efeitos dos fármacos , Córtex Renal/efeitos dos fármacos , Córtex Renal/patologia , Nefropatias/enzimologia , Nefropatias/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , NADPH Oxidases/biossíntese , NADPH Oxidases/genética , Óxido Nítrico/biossíntese , Oxirredução , Estresse Oxidativo/efeitos dos fármacos , Peroxidase/biossíntese , Peroxidase/genética , Distribuição Aleatória , Ratos , Ratos Wistar , Superóxido Dismutase/biossíntese , Superóxido Dismutase/genética , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Proteínas Quinases p38 Ativadas por Mitógeno/biossíntese , Proteínas Quinases p38 Ativadas por Mitógeno/genéticaRESUMO
BACKGROUND AND OBJECTIVE: It is unknown if pro- and anti-inflammatory mediators in acute lung inflammation induced by intestinal ischemia and reperfusion (i-I/R) can be modulated by low-level laser therapy (LLLT). STUDY DESIGN/MATERIAL AND METHODS: A controlled ex vivo study was developed in which rats were irradiated (660 nm, 30 mW, 0.08 cm² of spot size) on the skin over the right upper bronchus 1 hour post-mesenteric artery occlusion and euthanized 4 hours later. For pretreatment with anti-tumor necrosis factor (TNF) or IL-10 antibodies, the rats received either one of the agents 15 minutes before the beginning of reperfusion. METHODS: Lung edema was measured by the Evans blue extravasation and pulmonary neutrophils influx was determined by myeloperoxidase (MPO) activity. Both TNF and IL-10 expression and protein in lung were evaluated by RT-PCR and ELISA, respectively. RESULTS: LLLT reduced the edema (80.1 ± 41.8 µg g⻹ dry weight), neutrophils influx (0.83 ± 0.02 × 106 cells ml⻹), MPO activity (2.91 ± 0.60), and TNF (153.0 ± 21.0 pg mg⻹ tissue) in lung when compared with respective control groups. Surprisingly, the LLLT increased the IL-10 (0.65 ± 0.13) in lung from animals subjected to i-I/R. Moreover, LLLT (0.32 ± 0.07 pg ml⻹) reduced the TNF-α level in RPAECs when compared with i-I/R group. The presence of anti-TNF or IL-10 antibodies did not alter the LLLT effect on IL-10 (465.1 ± 21.0 pg mg⻹ tissue) or TNF (223.5 ± 21.0 pg mg⻹ tissue) in lung from animals submitted to i-I/R. CONCLUSION: The results indicate that the LLLT attenuates the i-I/R-induced acute lung inflammation which favor the IL-10 production and reduce TNF generation.
Assuntos
Interleucina-10/biossíntese , Intestinos/irrigação sanguínea , Isquemia/complicações , Terapia com Luz de Baixa Intensidade , Pneumonia/radioterapia , Reperfusão , Fator de Necrose Tumoral alfa/biossíntese , Doença Aguda , Animais , Edema , Lasers Semicondutores/uso terapêutico , Pulmão/metabolismo , Pulmão/patologia , Pulmão/efeitos da radiação , Masculino , Neutrófilos/efeitos da radiação , Peroxidase/biossíntese , Pneumonia/etiologia , Pneumonia/metabolismo , Pneumonia/patologia , Distribuição Aleatória , Ratos , Ratos WistarRESUMO
Dyslipidemia, and inflammatory markers: high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), lipoprotein associated phospholipase A2(Lp-PLA2), and lipid peroxides (LP) are insufficient to predict the onset, extent, and prognosis of CHD. Lipoxins (LXs), resolvins, and protectins are derived from omega-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and omega-6 arachidonic acid in the presence of aspirin; whereas nitrolipids are formed due to the interaction between polyunsaturated fatty acids and nitric oxide (NO). LXs, resolvins, protectins, and nitrolipids are endogenous anti-inflammatory lipid molecules that inhibit production of interleukin-6 (IL-6) and tumor necrosis factor- alpha (TNF-alpha), suppress free radical generation, enhance NO generation; and accelerate tissue repair. Thus, beneficial actions of EPA/DHA and aspirin in CHD could be attributed to the formation of LXs, resolvins, protectins, and nitrolipids and suggest that their plasma levels aid in the prediction and prognosis of CHD.
Assuntos
Biomarcadores/metabolismo , Doença das Coronárias/sangue , Doença das Coronárias/diagnóstico , Lipídeos/química , Proteína C-Reativa/biossíntese , Química Clínica/métodos , Ácidos Graxos/metabolismo , Humanos , Inflamação , Interleucina-6/biossíntese , Modelos Teóricos , Peroxidase/biossíntese , Fosfolipases A2/biossíntese , Prognóstico , Fatores de Risco , Fator de Necrose Tumoral alfa/biossínteseRESUMO
This study was carried out to determine if Ginkgo Biloba Extract (GBE or Egb 761) exerts a beneficial effect against cisplatin-induced renal failure in rats. Sprague Dawley rats were divided into four groups. The first group (control) received orally 1 mL/kg/day of 0.9% saline by an oral carrier vehicle on days 1 to 10. The second group was injected with 7 mg/kg cisplatin intraperitoneally (i.p.) on the fourth day, once only. The third group (vit E+cisplatin) was administered 10 mg/kg/day i.p. vit E on 1 to 10 days with one dose of i.p. cisplatin (7 mg/kg) injection on the fourth day. The fourth group (GBE+cisplatin) was given GBE orally at 100 mg/mL/kg started on the first day up to the tenth day with one dose of cisplatin (7 mg/kg) injection on the fourth day. Cisplatin was found to lead a statistically significant increase in plasma BUN and creatinine levels, as well as urine micro total protein (MTP) levels, leading to acute renal failure (ARF) in rats. Renal xanthine oxidase (XO) activities increased in all groups (statistically significant in cisplatin + GBE-treated rats; P < 0.001). Adenosine deaminase (AD) activities were increased in cisplatin-treated rats, and decreased in cisplatin+GBE-treated (P < 0.041) and cisplatin+vit E-treated (P < 0.005) rats, compared to controls. Malondialdehyde (MDA), nitric oxide (NO) levels and myeloperoxidase (MPO) activities were increased in the kidney tissue of cisplatin-treated rats. Vit E improved plasma creatinine and urine MTP levels, together with tissue MDA, NO levels, and MPO activities. But GBE had no statistically significant effect on those parameters. These results indicate that increased XO, AD and MPO activities, as well as MDA and NO levels play a critical role in cisplatin nephrotoxicity. GBE has been shown to protect against cisplatin-induced nephrotoxicity.
Assuntos
Antineoplásicos/toxicidade , Cisplatino/toxicidade , Ginkgo biloba , Insuficiência Renal/prevenção & controle , Adenosina Desaminase/biossíntese , Animais , História Antiga , Masculino , Malondialdeído/metabolismo , Óxido Nítrico/biossíntese , Peroxidase/biossíntese , Extratos Vegetais/farmacologia , Ratos , Ratos Sprague-Dawley , Insuficiência Renal/induzido quimicamente , Vitamina E/farmacologia , Xantina Oxidase/biossínteseRESUMO
Parkinson's disease (PD) is characterized by a loss of ventral midbrain dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Inflammatory oxidants have emerged as key contributors to PD- and MPTP-related neurodegeneration. Here, we show that myeloperoxidase (MPO), a key oxidant-producing enzyme during inflammation, is upregulated in the ventral midbrain of human PD and MPTP mice. We also show that ventral midbrain dopaminergic neurons of mutant mice deficient in MPO are more resistant to MPTP-induced cytotoxicity than their wild-type littermates. Supporting the oxidative damaging role of MPO in this PD model are the demonstrations that MPO-specific biomarkers 3-chlorotyrosine and hypochlorous acid-modified proteins increase in the brains of MPTP-injected mice. This study demonstrates that MPO participates in the MPTP neurotoxic process and suggests that inhibitors of MPO may provide a protective benefit in PD.
Assuntos
Encéfalo/enzimologia , Transtornos Parkinsonianos/enzimologia , Peroxidase/fisiologia , 1-Metil-4-Fenil-1,2,3,6-Tetra-Hidropiridina/farmacocinética , Esclerose Lateral Amiotrófica/enzimologia , Animais , Corpo Estriado/enzimologia , Dopamina/análise , Avaliação Pré-Clínica de Medicamentos , Indução Enzimática , Humanos , Doença de Huntington/enzimologia , Ácido Hipocloroso/análise , Masculino , Mesencéfalo/enzimologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Proteínas do Tecido Nervoso/química , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Estresse Oxidativo , Doença de Parkinson/enzimologia , Peroxidase/biossíntese , Peroxidase/deficiência , Peroxidase/genética , RNA Mensageiro/biossíntese , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tirosina/análogos & derivados , Tirosina/análiseRESUMO
This study was carried out to elucidate whether the protective activity of (-)-epicatechin 3-O-gallate (ECg) against excessive peroxynitrite (ONOO(-)) production, is distinct from the activity of several well-known free radical inhibitors, the ONOO(-) inhibitors ebselen and uric acid, the superoxide anion (O(2)(-)) scavenger copper zinc superoxide dismutase (CuZnSOD) and the selective inducible nitric oxide synthase inhibitor L-N(6)-(1-iminoethyl)lysine hydrochloride (L-NIL). To generate ONOO(-), male Wistar rats (n = 6/group) were subjected to ischaemia-reperfusion process together with lipopolysaccharide (LPS) injection. Although ECg did not scavenge the ONOO(-) precursors nitric oxide (NO) and O(2)(-), it reduced the 3-nitrotyrosine level, a property similar to that of uric acid, but distinct from L-NIL. In addition, the elevation in myeloperoxidase activity was reversed by the administration of ECg, uric acid and SOD, but not by that of L-NIL. Furthermore, ECg was the more potent scavenger of the ONOO(-) decomposition product, the hydroxyl radical (*OH), than any other free radical inhibitor tested. The LPS plus ischaemia-reperfusion process resulted in renal dysfunction, estimated by measuring the parameters of renal function--serum urea nitrogen and creatinine levels. However, administration of ECg ameliorated renal dysfunction more than that of the other free radical inhibitors. Moreover, ECg reduced the excessive uric acid level, while the others did not, suggesting a property of ECg distinct from the others. Furthermore, proteinuria, which was demonstrated by the low- and high-molecular weight (LMW and HMW) protein bands of the sodium dodecyl sulfate-polyacrylamide gel electrophoresis pattern, caused by LPS plus ischaemia-reperfusion, was attenuated by administration of ECg and L-NIL, after which the HMW band intensities decreased and LMW protein bands were absent. This study indicates that, in an in-vivo model of ONOO(-) generation, ECg, L-NIL and uric acid exert stronger protective activity against ONOO(-)-induced oxidative damage than SOD and ebselen, and that the mechanism whereby ECg protects against ONOO(-) is distinct from that of L-NIL or uric acid.
Assuntos
Catequina/uso terapêutico , Lisina/análogos & derivados , Tirosina/análogos & derivados , Animais , Azóis/administração & dosagem , Azóis/farmacologia , Nitrogênio da Ureia Sanguínea , Catequina/administração & dosagem , Catequina/análogos & derivados , Catequina/isolamento & purificação , Cobre/química , Creatinina/sangue , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Sequestradores de Radicais Livres/antagonistas & inibidores , Isoindóis , Japão , Rim/irrigação sanguínea , Rim/enzimologia , Rim/lesões , Lipopolissacarídeos/administração & dosagem , Lipopolissacarídeos/efeitos adversos , Lisina/administração & dosagem , Lisina/farmacocinética , Masculino , Óxido Nítrico/biossíntese , Óxido Nítrico/sangue , Compostos Organosselênicos/administração & dosagem , Compostos Organosselênicos/farmacologia , Peroxidase/antagonistas & inibidores , Peroxidase/biossíntese , Peroxidase/metabolismo , Fitoterapia , Extratos Vegetais/uso terapêutico , Raízes de Plantas/química , Proteinúria/metabolismo , Ratos , Ratos Wistar , Traumatismo por Reperfusão/complicações , Rheum/química , Superóxido Dismutase/administração & dosagem , Superóxido Dismutase/farmacologia , Tirosina/agonistas , Tirosina/biossíntese , Tirosina/sangue , Ácido Úrico/sangue , Zinco/químicaRESUMO
Dietary antioxidants may attenuate oxidative damage from strenuous exercise in various tissues. Beneficial effects of the antioxidant astaxanthin have been demonstrated in vitro, but not yet in vivo. We investigated the effect of dietary supplementation with astaxanthin on oxidative damage induced by strenuous exercise in mouse gastrocnemius and heart. C57BL/6 mice (7 weeks old) were divided into groups: rested control, intense exercise, and exercise with astaxanthin supplementation. After 3 weeks of exercise acclimation, both exercise groups ran on a treadmill at 28 m/min until exhaustion. Exercise-increased 4-hydroxy-2-nonenal-modified protein and 8-hydroxy-2'-deoxyguanosine in gastrocnemius and heart were blunted in the astaxanthin group. Increases in plasma creatine kinase activity, and in myeloperoxidase activity in gastrocnemius and heart, also were lessened by astaxanthin. Astaxanthin showed accumulation in gastrocnemius and heart from the 3 week supplementation. Astaxanthin can attenuate exercise-induced damage in mouse skeletal muscle and heart, including an associated neutrophil infiltration that induces further damage.
Assuntos
Desoxiguanosina/análogos & derivados , Músculo Esquelético/metabolismo , Miocárdio/metabolismo , beta Caroteno/análogos & derivados , beta Caroteno/farmacologia , 8-Hidroxi-2'-Desoxiguanosina , Adjuvantes Imunológicos/farmacologia , Animais , Antioxidantes/farmacologia , Creatina Quinase/biossíntese , Creatina Quinase/sangue , Creatina Quinase/metabolismo , Desoxiguanosina/farmacologia , Suplementos Nutricionais , Feminino , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos C57BL , Estresse Oxidativo , Peroxidase/biossíntese , Peroxidase/sangue , Peroxidase/metabolismo , Condicionamento Físico Animal , XantofilasRESUMO
Antithrombin (AT) supplementation in patients with severe sepsis has been shown to improve organ failures in which activated leukocytes are critically involved. However, the precise mechanism(s) for the therapeutic effects of AT is not well understood. We examined in rats whether AT reduces ischemia/reperfusion (I/R)-induced renal injury by inhibiting leukocyte activation. AT markedly reduced the I/R-induced renal dysfunction and histologic changes, whereas neither dansyl glutamylglycylarginyl chloromethyl ketone-treated factor Xa (DEGR-F.Xa), a selective inhibitor of thrombin generation, nor Trp49-modified AT, which lacks affinity for heparin, had any effect. Renal tissue levels of 6-keto-PGF(1 alpha), a stable metabolite of prostacyclin (PGI(2)), increased after renal I/R. AT enhanced the I/R-induced increases in renal tissue levels of 6-keto-PGF(1 alpha), whereas neither DEGR-F.Xa nor Trp49-modified AT had any effect. AT significantly inhibited I/R-induced decrease in renal tissue blood flow and the increase in the vascular permeability. Ischemia/reperfusion-induced increases in renal tissue levels of tumor necrosis factor-alpha, cytokine-induced neutrophil chemoattractant, and myeloperoxidase were significantly inhibited in animals given AT. Pretreatment of animals with indomethacin reversed the effects induced by AT. Iloprost, an analog of PGI(2), produced effects similar to those induced by AT. These observations strongly suggest that AT reduces the I/R-induced renal injury by inhibiting leukocyte activation. The therapeutic effects of AT might be mainly mediated by PGI(2) released from endothelial cells through interaction of AT with cell surface glycosaminoglycans.
Assuntos
6-Cetoprostaglandina F1 alfa/biossíntese , Anti-Inflamatórios não Esteroides/uso terapêutico , Antitrombina III/uso terapêutico , Endotélio Vascular/efeitos dos fármacos , Epoprostenol/biossíntese , Isquemia/tratamento farmacológico , Rim/irrigação sanguínea , Ativação Linfocitária/efeitos dos fármacos , Traumatismo por Reperfusão/prevenção & controle , 6-Cetoprostaglandina F1 alfa/genética , Clorometilcetonas de Aminoácidos/farmacologia , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Antitrombina III/farmacologia , Permeabilidade Capilar/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Endotélio Vascular/metabolismo , Epoprostenol/genética , Fator Xa/farmacologia , Iloprosta/farmacologia , Iloprosta/uso terapêutico , Indometacina/farmacologia , Indometacina/uso terapêutico , Isquemia/imunologia , Isquemia/metabolismo , Rim/patologia , Masculino , Peroxidase/biossíntese , Peroxidase/genética , Ratos , Ratos Wistar , Traumatismo por Reperfusão/imunologia , Traumatismo por Reperfusão/metabolismo , Organismos Livres de Patógenos Específicos , Fator de Necrose Tumoral alfa/biossíntese , Fator de Necrose Tumoral alfa/genéticaRESUMO
Components of betel quid (BQ) have been investigated for genotoxicity, mutagenicity, and animal toxicity. However, little information exists regarding their carcinogenic characteristics. Considerable attention has already been focused on tumor promoters that occur environmentally for human uptake. In this study, the promoting effects of BQ and lime-piper additives (LPA) in BQ on epidermal hyperplasia in CD-1 mouse skin are investigated. In the present study, we found that BQ and LPA at concentrations of 25,50,75 mg/ml caused significant induction of hyperplasia, but only LPA caused an increase of epidermal ornithine decarboxylase (ODC). Treatment of mouse skin with LPA caused remarkable increases in the production of H(2)O(2) by 2.41-, 3.90-, and 3.76-fold (for the above-indicated concentrations respectively); as well as marked increases of myeloperoxidase (MPO) by 1.43-, 2.70-, and 2.29-fold. Application of LPA or BQ (50,100,150 mg/ml) also caused induction of protein kinase C-alpha (PKC-alpha) and NF-kappaB. LPA exhibited more significant effect than BQ. Thus, LPA might make a major contribution to the BQ-induced expression of PKC and NF-kappaB. These results indicated that BQ has the potential of being promoting agents, and that LPA should play a major role in increasing the effects of BQ-caused skin hyperplasia and inflammation. The promoting effects of BQ and LPA on mouse skin were associated with the induction of the expressions of PKC and NF-kappaB.
Assuntos
Areca/efeitos adversos , Compostos de Cálcio/efeitos adversos , Carcinógenos/efeitos adversos , Epiderme/efeitos dos fármacos , NF-kappa B/biossíntese , Óxidos/efeitos adversos , Extratos Vegetais/efeitos adversos , Proteína Quinase C/biossíntese , Animais , Areca/química , Western Blotting , Compostos de Cálcio/química , Carcinógenos/química , Divisão Celular , Relação Dose-Resposta a Droga , Epiderme/metabolismo , Epiderme/patologia , Feminino , Peróxido de Hidrogênio/metabolismo , Hiperplasia/induzido quimicamente , Hiperplasia/metabolismo , Hiperplasia/patologia , Camundongos , Óxidos/química , Peroxidase/biossíntese , Piper , Extratos Vegetais/químicaRESUMO
BACKGROUND AND AIM: We evaluated the effect of rebamipide (2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl] propionic acid), a novel anti-ulcer drug, on indomethacin-induced small intestinal lesions in rats. METHODS: The animals were administered indomethacin (10 mg/kg, s.c.), and they were killed 24 h later. Rebamipide (30-300 mg/kg) was administered p.o. twice, 30 min before, and 6 h after indomethacin. RESULTS: Indomethacin caused hemorrhagic lesions in the rat small intestine, accompanied by an increase in enterobacterial translocation, inducible nitric oxide synthase (iNOS) and myeloperoxidase (MPO) activities, as well as thiobarbituric acid (TBA) reactants, and these changes were significantly prevented by the supplementation with 16,16-dimethyl prostaglandin E2 (dmPGE2; 10 microg/kg, i.v.) or the pretreatment of animals with the antibiotic ampicillin. Treatment of the animals with rebamipide dose-dependently prevented the development of intestinal lesions, and this effect was mimicked by i.v. administration of superoxide dismutase (SOD: 3000 U/kg) + catalase (CAT: 5000 U/kg). The protection by rebamipide was accompanied by a significant suppression of the increase in both MPO and iNOS activities, and a complete inhibition of the increase in TBA reactants, while SOD + CAT significantly inhibited the increase of MPO activity and TBA reactants, but not iNOS activity. The bacterial translocation following indomethacin was also significantly decreased by either rebamipide or SOD + CAT. CONCLUSION: These results confirmed the importance of enterobacteria and iNOS/NO in the pathogenesis of indomethacin-induced small intestinal lesions, and suggested that rebamipide prevents the development of these lesions, probably by its radical scavenging action.
Assuntos
Alanina/análogos & derivados , Alanina/farmacologia , Antiulcerosos/farmacologia , Inibidores Enzimáticos/farmacologia , Enteropatias/prevenção & controle , Quinolonas/farmacologia , Ampicilina/farmacologia , Animais , Translocação Bacteriana/efeitos dos fármacos , Catalase/farmacologia , Relação Dose-Resposta a Droga , Enterobacteriaceae/efeitos dos fármacos , Indometacina , Enteropatias/induzido quimicamente , Enteropatias/enzimologia , Peroxidação de Lipídeos , Masculino , Óxido Nítrico Sintase/biossíntese , Peroxidase/biossíntese , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/farmacologiaRESUMO
1. Chemokine expression and function was monitored in an experimental model of granulomatous tissue formation after injection of croton oil in complete Freund's adjuvant (CO/CFA) into mouse dorsal air-pouches up to 28 days. 2. In the first week, mast cell degranulation and leukocyte influx (mononuclear cell, MNC, and polymorphonuclear cell, PMN) were associated with CXCR2, KC and macrophage inflammatory protein (MIP)-2 mRNA expression, as determined by TaqMan reverse transcriptase-polymerase chain reaction. KC ( approximately 400 pg x mg protein(-1), n=12) and MIP-2 (approximately 800 pg x mg protein(-1), n=12) proteins peaked at day 7, together with myeloperoxidase (MPO) activity. Highest MIP-1alpha (>1 ng x mg protein(-1), n=12) levels were measured at day 3. 3. After day 7, a gradual increase in CCR2 and CCR5 mRNA, monocyte chemoattractant protein (MCP)-1 mRNA and protein expression was measured. MCP-1 protein peaked at day 21 (approximately 150 pg x mg protein(-1), n=12) and was predominantly expressed by mast cells. A gradual increase in N-acetyl-beta-D-glucosaminidase (NAG) activity (maximal at 28 days) was also measured. 4. An antiserum against MIP-1alpha did not modify the inflammatory response measured at day 7 (except for a 50% reduction in MIP-1alpha levels), but provoked a significant increase in MPO, NAG and MCP-1 levels as measured at day 21 (n=6, P<0.05). An antiserum to MCP-1 reduced NAG activity at day 21 but increased MPO activity values (n=8, P<0.05). 5. In conclusion, we have shown that CO/CFA initiates a complex inflammatory reaction in which initial expression of MIP-1alpha serves a protective role whereas delayed expression of MCP-1 seems to have a genuine pro-inflammatory role.
Assuntos
Quimiocina CCL2/fisiologia , Quimiocinas/biossíntese , Proteínas Inflamatórias de Macrófagos/fisiologia , Receptores de Quimiocinas/biossíntese , Animais , Quimiocina CCL2/biossíntese , Quimiocina CCL2/genética , Quimiocina CCL3 , Quimiocina CCL4 , Quimiocinas/genética , Óleo de Cróton/farmacologia , Modelos Animais de Doenças , Feminino , Adjuvante de Freund/farmacocinética , Imuno-Histoquímica , Inflamação/tratamento farmacológico , Leucócitos/imunologia , Proteínas Inflamatórias de Macrófagos/biossíntese , Proteínas Inflamatórias de Macrófagos/genética , Mastócitos/efeitos dos fármacos , Camundongos , Peroxidase/biossíntese , Peroxidase/genética , Peroxidase/fisiologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismoRESUMO
The herb Desmotrichum fimbriatum Bl. (family: Orchidaceae), sold as Jibanti in West Bengal, is used in 'Rasayana therapy' in Ayurveda. Its effect on the modulation of the two antioxidant enzymes peroxidase and catalase has been studied in mice liver during 'cold water swim' (CWS) stress using appropriate controls. The drug, i.e. the aqueous ethanolic extract of the herb (whole plant) was found to increase peroxidase titre in the hepatic cells of normal mice. But in the stressed group, the drug displayed no effect on the peroxidase content, while it elicited an elevation of the catalase content. infinity-Tocoferol was used as the standard drug. These data suggested that the drug can ameliorate the peroxidative damage caused in mice by CWS stress.
Assuntos
Antioxidantes/farmacologia , Magnoliopsida , Plantas Medicinais , Animais , Catalase/biossíntese , Indução Enzimática/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Ayurveda , Camundongos , Peroxidase/biossíntese , Fitoterapia , Extratos Vegetais/farmacologia , Estresse Fisiológico/tratamento farmacológico , Estresse Fisiológico/enzimologiaRESUMO
BACKGROUND AND AIM: Zinc enhances cell protection against infection and injury and the healing processes themselves. We evaluated the effect of zinc supplementation at different doses on a model of experimental colitis in the rat. METHODS: Colitis, induced by intra-rectal instillation of dinitrobenzen-sulphonic acid, was assessed at 1 week by examining: general outcome and macroscopic damage, myeloperoxidase activity, mucosal zinc, iron and metallothionein concentrations. Rats received zinc sulphate, 2 mg/kg or 30 mg/kg, twice a day by gavage for 9 days, starting 3 days before the induction of colitis, or intrarectal instillation of zinc (20 mg/kg) once daily starting 8 hours after the induction of colitis and for 6 days thereafter RESULTS: Zinc-treated rats had less diarrhoea, higher body weight and lower colonic weight than untreated rats but no effect was observed on macroscopic inflammation, adhesions, colonic distension and neutrophil infiltration of the colonic mucosa. Zinc supplementation did not affect mucosal iron and zinc concentrations or plasma zinc levels in colitic rats. Metallothionein synthesis was induced in control rats and to a lesser extent in colitic rats. CONCLUSION: Zinc administration induces metallothionein synthesis but has little effect on the short-term course of experimental colitis.
Assuntos
Colite/tratamento farmacológico , Mucosa Intestinal/química , Metalotioneína/análise , Oligoelementos/análise , Zinco/administração & dosagem , Administração Oral , Administração Retal , Análise de Variância , Animais , Colite/metabolismo , Colite/fisiopatologia , Suplementos Nutricionais , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Mucosa Intestinal/patologia , Masculino , Metalotioneína/biossíntese , Peroxidase/análise , Peroxidase/biossíntese , Probabilidade , Distribuição Aleatória , Ratos , Ratos Sprague-DawleyRESUMO
This comparative study investigates the mechanism of cadmium accumulation in the semiaquatic plant Nymphoides peltata (Menyanthaceae) and the aquatic plant Nymphaea (Nymphaeaceae). It was conducted as part of an ongoing study of the use of water plants for phytoremediation. Epidermal structures, known as hydropotes, are located on the abaxial epidermis of the leaf laminae of Nymphoides peltata and are shown to contain phenols, peroxidase and polyphenol oxidase activities. When plants are subjected to 50 mg/l of cadmium in the growth medium, these hydropotes accumulate cadmium. Cadmium-induced increases in phenols, peroxidase and polyphenol oxidase activities were determined in plant extracts. Cadmium binding by polymerized phenols was demonstrated in vivo. In comparison with Nymphaeae epidermal glands, N. peltata hydropotes are larger, open, and create bigger crystal, the latter principally composed of calcium and, proportionally, less cadmium. Although both plants showed similar levels of cadmium accumulation, N. peltata was sensitive while Nymphaeae was resistant to this cadmium level. It is suggested that in these water plants the main mechanism for cadmium accumulation is based on the trapping of cadmium crystals by polymerized phenols in specialized epidermal structures and this is due to peroxidase and polyphenol oxidase activities. Nymphaeae, with greater peroxidase activity and more polyphenols, is more resistant to this heavy metal than N. peltata.